Boston, MA, United States of America

Kris Lowe

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator Profile: Kris Lowe

Introduction

Kris Lowe is a notable inventor based in Boston, MA, who has made significant contributions to the field of medical therapies. With a total of eight patents to his name, his work focuses on innovative methods and compositions aimed at enhancing the delivery of essential enzymes for treating lysosomal storage diseases.

Latest Patents

Kris Lowe's latest patents include "Methods and compositions for CNS delivery of iduronate-2-sulfatase." This invention provides compositions and methods for effectively delivering lysosomal enzymes to the central nervous system (CNS). It includes a stable formulation designed for direct CNS intrathecal administration, comprising iduronate-2-sulfatase (I2S) protein, salt, and a polysorbate surfactant to facilitate treatment for Hunter Syndrome. This work illustrates the potential for better therapeutic interventions for conditions that have been historically challenging to treat.

Career Highlights

Throughout his career, Kris has worked with leading companies in the pharmaceutical industry, including Shire Human Genetic Therapies, Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to hone his expertise in genetic therapies, furthering his impact on medical advancements.

Collaborations

Kris Lowe's success is also attributed to his collaborative efforts with remarkable colleagues, such as Gaozhong Zhu and Zahra Shahrokh. Working alongside talented professionals has enabled him to explore novel approaches in the development of therapies, fostering an environment conducive to innovation.

Conclusion

Kris Lowe is a pioneering inventor whose work is helping to reshape the landscape of treatments for lysosomal storage diseases. His latest advancements in CNS delivery systems represent a significant step forward in medicine. As he continues to innovate and collaborate with others in the field, the potential for impactful breakthroughs in therapeutic strategies remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…